Biome Australia enters UK and Ireland health retail markets

The company recently signed commercial agreements with UK-based CLF and Ireland-based iiHealthfood

Biome Australia (BIO) is set to launch its activated probiotics in the United Kingdom and the Republic of Ireland.

It has started delivering the first allocation of the products into pharmacy and health retail stores across the countries, which are intended to be stocked at multiple distribution centres for nationwide consumption.

The European launch follows the recent signing of commercial agreements between the Australian company and UK-based CLF and Ireland-based iiHealthfood.

Biome’s team would be managing all aspects of training, support and customer service to ensure the sales model is consistent with the Australian market, the company said.

BIO Managing Director and founder, Blair Norfolk told The Market Herald that the launch of activated probiotics into UK and Ireland health retail markets demonstrates their “ability to both execute and scale into new international markets.”

“We are confident that we have the right elements in place for these markets to add material value to the Biome business over coming years and will also strengthen our ability to support new patients, improve their health outcomes, and quality of life and make our products accessible to all – that remains our core mission,” he added.

Biome conducted a successful test market phase in both countries with a focus on independent health practitioners, helping it acquire a strong foundational customer and revenue base.

Activated Probiotics are Biome’s flagship range of live biotherapeutic products which have been clinically proven to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome (IBS).

The Australian company also develop and distributes scientifically formulated, organic nutraceutical range called Activated Nutrients.